ConductScience.org, home

Paper33200026

Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor.

Pan B and 7 others. Comput Struct Biotechnol J, 2020. Cited by 75 papers, by iCite.

Cite this record

ConductScience Library. Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor. Papers, record 33200026. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33200026

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chinese herbal compounds against SARS-CoV-2: Puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor.
PubMed
Journal
Comput Struct Biotechnol J
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
75
iCite
Relative citation ratio, by iCite
3.96
iCite
Revised in PubMed
2024-04-04
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pan BBoyu
2Fang SSenbiao
3Zhang JJu
4Pan YYa
5Liu HHan
6Wang YYun
7Li MMin
8Liu LLiren

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127951737A systematic review of the active saikosaponins and extracts isolated from Radix Bupleuri and their applications.Pharm Biol2017https://conductscience.org/library/papers/27951737PubMed
214531019Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species.Planta Med2003https://conductscience.org/library/papers/14531019PubMed
332020029Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.Cell Res2020https://conductscience.org/library/papers/32020029PubMed
414647384Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.Nature2003https://conductscience.org/library/papers/14647384PubMed
532075786Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.BMJ2020https://conductscience.org/library/papers/32075786PubMed
632139372What we know so far: COVID-19 current clinical knowledge and research.Clin Med (Lond)2020https://conductscience.org/library/papers/32139372PubMed
732094589Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.Nat Microbiol2020https://conductscience.org/library/papers/32094589PubMed
821172056Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae.BMC Bioinformatics2010https://conductscience.org/library/papers/21172056PubMed
932113846In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus.J Integr Med2020https://conductscience.org/library/papers/32113846PubMed
1035539671Uncovering the action mechanism of polydatin via network pharmacological target prediction.RSC Adv2018https://conductscience.org/library/papers/35539671PubMed
1123787177Traditional Chinese medicine network pharmacology: theory, methodology and application.Chin J Nat Med2013https://conductscience.org/library/papers/23787177PubMed
1232225176Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.Nature2020https://conductscience.org/library/papers/32225176PubMed
1332663409Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.Am J Respir Crit Care Med2020https://conductscience.org/library/papers/32663409PubMed
1432205232Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).Pharmacol Res2020https://conductscience.org/library/papers/32205232PubMed
1524339367Puerarin: a review of pharmacological effects.Phytother Res2014https://conductscience.org/library/papers/24339367PubMed
1628593176Radix Bupleuri: A Review of Traditional Uses, Botany, Phytochemistry, Pharmacology, and Toxicology.Biomed Res Int2017https://conductscience.org/library/papers/28593176PubMed
1722205743Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits.J Virol2012https://conductscience.org/library/papers/22205743PubMed
1823486063Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.Nature2013https://conductscience.org/library/papers/23486063PubMed
1933867046Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial.Phytomedicine2021https://conductscience.org/library/papers/33867046PubMed
2031986264Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet2020https://conductscience.org/library/papers/31986264PubMed

See all 29 referencesDownload CSV of references

Cited by60

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.

PMIDTitleJournalYearIn PapersSource
42792123Bioactive Phenolics from Medemia argun: Biological Activities, Molecular Docking, Encapsulation in Alginate-Whey Protein Hydrogel Beads, and Functional Yoghurt Fortification.Antioxidants (Basel)2026https://conductscience.org/library/papers/42792123PubMed
42589207Quercetin in COPD: A Multi-Target Approach to Modulate Inflammation, Oxidative Stress, and Epithelial Dysfunction.Int J Mol Sci2026https://conductscience.org/library/papers/42589207PubMed
40477955CEBIT screening for inhibitors of the interaction between SARS-CoV-2 spike and ACE2.Fundam Res2022https://conductscience.org/library/papers/40477955PubMed
39860053Immune-Boosting and Antiviral Effects of Antioxidants in COVID-19 Pneumonia: A Therapeutic Perspective.Life (Basel)2025https://conductscience.org/library/papers/39860053PubMed
39572758Saikogenin A improves ethanol-induced liver injury by targeting SIRT1 to modulate lipid metabolism.Commun Biol2024https://conductscience.org/library/papers/39572758PubMed
39468922From complexity to clarity: development of CHM-FIEFP for predicting effective components in Chinese herbal formulas by using big data.Cancer Biol Med2024https://conductscience.org/library/papers/39468922PubMed
39310702Bryophyllum pinnatum (Lam.) Oken: unravelling therapeutic potential and navigating toxicity.Physiol Mol Biol Plants2024https://conductscience.org/library/papers/39310702PubMed
39285019Establishment of in-house assay for screening of anti-SARS-CoV-2 protein inhibitors.AMB Express2024https://conductscience.org/library/papers/39285019PubMed
39063143A Natural Bioactive Peptide from Pinctada fucata Pearls Can Be Used as a Potential Inhibitor of the Interaction between SARS-CoV-2 and ACE2 against COVID-19.Int J Mol Sci2024https://conductscience.org/library/papers/39063143PubMed
39021910Quercetin as one of the most abundant represented biological valuable plant components with remarkable chemoprotective effects - A review.Heliyon2024https://conductscience.org/library/papers/39021910PubMed
38765079Therapeutic implications of quercetin and its derived-products in COVID-19 protection and prophylactic.Heliyon2024https://conductscience.org/library/papers/38765079PubMed
38709267The beneficial health effects of puerarin in the treatment of cardiovascular diseases: from mechanisms to therapeutics.Naunyn Schmiedebergs Arch Pharmacol2024https://conductscience.org/library/papers/38709267PubMed
38510013Bibliometric analysis and key messages of integrating Chinese and Western Medicine for COVID-19.Heliyon2024https://conductscience.org/library/papers/38510013PubMed
38273400Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2.Virol J2024https://conductscience.org/library/papers/38273400PubMed
38138562Microfluidic Diffusion Sizing Applied to the Study of Natural Products and Extracts That Modulate the SARS-CoV-2 Spike RBD/ACE2 Interaction.Molecules2023https://conductscience.org/library/papers/38138562PubMed
37881508Quercetin: A promising drug candidate against the potential SARS-CoV-2-Spike mutants with high viral infectivity.Comput Struct Biotechnol J2023https://conductscience.org/library/papers/37881508PubMed
37834240Plant Cell-Engineered Gold Nanoparticles Conjugated to Quercetin Inhibit SARS-CoV-2 and HSV-1 Entry.Int J Mol Sci2023https://conductscience.org/library/papers/37834240PubMed
37675874Extracts of Thesium chinense inhibit SARS-CoV-2 and inflammation in vitro.Pharm Biol2023https://conductscience.org/library/papers/37675874PubMed
37600392Luteolin and triptolide: Potential therapeutic compounds for post-stroke depression via protein STAT.Heliyon2023https://conductscience.org/library/papers/37600392PubMed
37430747Application of the Nicoya OpenSPR to Studies of Biomolecular Binding: A Review of the Literature from 2016 to 2022.Sensors (Basel)2023https://conductscience.org/library/papers/37430747PubMed

See all 60 cited byDownload CSV of cited by

Genes33

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL227PubTator's text mininghttps://conductscience.org/library/genes/27NCBI Gene
ACE259272PubTator's text mininghttps://conductscience.org/library/genes/59272NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CASP8841PubTator's text mininghttps://conductscience.org/library/genes/841NCBI Gene
CXCL103627PubTator's text mininghttps://conductscience.org/library/genes/3627NCBI Gene
CXCL22920PubTator's text mininghttps://conductscience.org/library/genes/2920NCBI Gene
CYP1A11543PubTator's text mininghttps://conductscience.org/library/genes/1543NCBI Gene
CYP1A21544PubTator's text mininghttps://conductscience.org/library/genes/1544NCBI Gene
CYP1B11545PubTator's text mininghttps://conductscience.org/library/genes/1545NCBI Gene
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051NCBI Gene
DPP41803PubTator's text mininghttps://conductscience.org/library/genes/1803NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
GSTK1373156PubTator's text mininghttps://conductscience.org/library/genes/373156NCBI Gene
GSTM12944PubTator's text mininghttps://conductscience.org/library/genes/2944NCBI Gene
GSTM22946PubTator's text mininghttps://conductscience.org/library/genes/2946NCBI Gene

See all 33 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33200026

GET https://conductscience.org/api/papers/v1/33200026/references?page=2